|
|||||
|
|
Initial Report of Second-Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi-Institutional Retrospective Analysis |
|
| Authors: | Samuel J Klempner Steven B Maron Leah Chase Samantha Lomnicki Zev A Wainberg Daniel VT Catenacci |
| Institution: | 1. The Angeles Clinic and Research Institute, Los Angeles, California, USA;2. Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois, USA
Contributed equally;3. Department of Medicine, Section of Hematology/Oncology, University of Chicago Medical Center and Biological Sciences, Chicago, Illinois, USA;4. Division of Hematology/Oncology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA |
| Abstract: | |
| Keywords: | Gastric cancer GEJ adenocarcinoma Ramucirumab FOLFIRI Second line |